Skip to main content
Top
Published in: Internal and Emergency Medicine 2/2012

01-04-2012 | CE - LETTER TO THE EDITOR

Asymptomatic acute myocardial injury during allergic reaction to hymenoptera venom

Author: Christian Leli

Published in: Internal and Emergency Medicine | Issue 2/2012

Login to get access

Excerpt

A 58-year-old man was admitted to the emergency department (ED) with the complaint of generalized pruritis, profuse sweating, malaise and presyncope that had started after being stung by a wasp on his left shoulder around 3 h prior, and worsened with time. He denied chest or abdominal pain. He had no history of cardiac risk factors or allergy, and he was taking no regular medications. Hypotension (90/60 mmHg) was observed. The room air arterial oxygen saturation was of 97%, the heart rate was 69 beats/min. and regular, body temperature was 36.3°C. Except for diaphoresis, the physical examination was normal. Treatment was started with 1 g of hydrocortisone sodium succinate, 10 mg of chlorphenamine and 50 mg of ranitidine intravenously, with subsequent normalization of the blood pressure (122/84 mmHg). No adrenaline was administered. The electrocardiogram did not show signs of ischemia (Fig. 1a). Because of the possible relation between allergic reactions and myocardial ischemia, cardiac biomarkers were determined. Blood tests revealed increased values of troponin I (1.53 ng/mL; reference range (RR) 0–0.06), creatine kinase–MB fraction (23.2 ng/mL; RR <6 ng/mL) and myoglobin (229.5 ng/mL; RR ≤90 ng/mL). Moreover, a blood count revealed leukocytosis (20,920/mm3; RR 4,000–11,000) with no increased number of eosinophils (20/mm3; RR 0–400) or basophils (10/mm3; RR 0–50). C-reactive protein was also increased (4.60 mg/dL; RR 0–1). A coagulation screening showed an increase of the D-dimer (659 ng/mL; RR 0–230). The remaining parameters, renal and liver function, electrolytes, lipid profile, serum proteins electrophoresis, total creatine kinase, Antithrombin III, were within normal limits. A chest X-ray study was normal.
Literature
1.
2.
go back to reference Busti C, Falcinelli E, Momi S, Gresele P (2010) Matrix metalloproteinases and peripheral arterial disease. Intern Emerg Med 5:13–25PubMedCrossRef Busti C, Falcinelli E, Momi S, Gresele P (2010) Matrix metalloproteinases and peripheral arterial disease. Intern Emerg Med 5:13–25PubMedCrossRef
3.
go back to reference Biteker M (2010) A new classification of Kounis syndrome. Int J Cardiol (Jun 7) Biteker M (2010) A new classification of Kounis syndrome. Int J Cardiol (Jun 7)
4.
go back to reference Cugno M, Marzano AV, Asero R, Tedeschi A (2010) Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications. Intern Emerg Med 5:97–101PubMedCrossRef Cugno M, Marzano AV, Asero R, Tedeschi A (2010) Activation of blood coagulation in chronic urticaria: pathophysiological and clinical implications. Intern Emerg Med 5:97–101PubMedCrossRef
5.
go back to reference Almpanis G, Siahos S, Karogiannis NC, Mazarakis A, Niarchos C, Kounis GN, Kounis NG (2009) Kounis syndrome: two extraordinary cases. Int J Cardiol Almpanis G, Siahos S, Karogiannis NC, Mazarakis A, Niarchos C, Kounis GN, Kounis NG (2009) Kounis syndrome: two extraordinary cases. Int J Cardiol
Metadata
Title
Asymptomatic acute myocardial injury during allergic reaction to hymenoptera venom
Author
Christian Leli
Publication date
01-04-2012
Publisher
Springer Milan
Published in
Internal and Emergency Medicine / Issue 2/2012
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-011-0558-y

Other articles of this Issue 2/2012

Internal and Emergency Medicine 2/2012 Go to the issue

CE - LETTER TO THE EDITOR

Hypokalemia-induced T–U fusion

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine